HyperTEENsion: Raising awareness, not blood pressure
27 Feb 2026
By Ronald Allan M. Ponteres, MD, MBAH
As pediatric experts sound the alarm, emerging body of evidence shows that high blood pressure is no longer an adults‑only condition. Filipino clinicians are being urged to screen earlier, act sooner, and mobilize families, schools, and local governments to make healthy choices the default for adolescents.
Dr Maria Theresa Hernal, a pediatrician and pharmaceutical medicine specialist, opens with a clear definition that highlights the stakes. “Pediatric hypertension is defined as having elevated systolic or diastolic blood pressure readings for the patient’s age, height and sex on three different occasions. For children 1 to <13 years of age, BP is categorized by percentiles. For children >13 years of age, elevated BP is systolic blood pressure (sBP) between 120 and 129 mmHg with a diastolic BP (dBP) <80 mmHg; stage 1 hypertension is defined as BP between 130/80 to 139/89 mmHg and Stage 2 hypertension is BP >140/90 mmHg.” She adds that for adolescents, “the definition for hypertension is aligned with the adult guidelines for the detection of elevated BP.”
Urgent relevance
Adolescent hypertension, defined in pediatric guidance as BP ≥130/80 mmHg in those aged 13–17 years, follows into adulthood and is linked with early organ changes such as left ventricular hypertrophy and increased arterial stiffness. These are not distant complications; they begin quietly in the teen years, reshaping cardiovascular outcomes (Khoury & Urbina, 2021; Hardy & Urbina, 2021). Dr Hernal’s clinical message mirrors the literature: early identification changes the curve of risk. “As a pediatrician, elevated BP should be treated proactively even though asymptomatic, focusing on lifestyle and close follow‑up. Early intervention is important as early damage occurs silently, tracks into adulthood, and prevention is easier than treatment. Pediatricians should reassure families that early intervention does not mean medication, rather it means protecting the teen’s future cardiovascular health.”
Population burden
Global estimates suggest that 4–6% of children and adolescents have hypertension, with rates rising sharply among those with obesity or chronic kidney disease (Gartlehner et al., 2020). In the Philippines, the Expanded National Nutrition Survey (ENNS) offers rolling surveillance of noncommunicable disease (NCD) risk factors, including BP, an infrastructure that positions provinces and highly urbanized cities to plan targeted interventions (Patalen et al., 2020). While consolidated national prevalence for adolescent BP from ENNS is still being synthesized across survey cycles, the system itself signals a maturing capacity to detect, track, and respond at scale (Gartlehner et al., 2020; Patalen et al., 2020). Pressure triggers
Primary (essential) hypertension has become increasingly common in adolescents, reflecting lifestyle and environmental changes: high sodium intake, low dietary fiber and potassium, insufficient sleep, sedentary behavior, psychosocial stress, and hereditary risk (Hardy & Urbina, 2021). Secondary causes, less frequent in teens than in younger children, remain clinically crucial to consider, including renal parenchymal or renovascular disease, endocrine disorders, coarctation of the aorta, and medication effects such as stimulants or steroids (Baker-Smith et al., 2018; Hardy & Urbina, 2021).
Silent but not benign
Most adolescents with hypertension have no symptoms. When present, symptoms are nonspecific (e.g. headaches, dizziness, visual disturbances, epistaxis, palpitations, or decreased exercise tolerance), making routine measurement essential (AAFP, 2018; Baker-Smith et al., 2018). Red flags for a secondary cause include severe or resistant BP elevation, onset before puberty, abnormal urinalysis or renal function, endocrine features (e.g., hyperthyroid symptoms), or diminished femoral pulses suggestive of coarctation (AAFP, 2018; Baker-Smith et al., 2018). Dr Hernal cautions that damage accumulates quietly: “Early damage occurs silently… and prevention is easier than treatment.”
Early detection
Clinic BP is the starting point, but proper technique and repeat measurements with the correct cuff size are non-negotiable. Because office readings can miss masked hypertension or overcall white‑coat hypertension, the 2017 American Academy of Pediatrics (AAP) guideline and subsequent statements recommend 24‑hour ambulatory blood pressure monitoring (ABPM) to confirm diagnosis when available. ABPM correlates better with target‑organ damage than clinic BP and helps tailor therapy; where ABPM access is limited, as in many settings outside subspecialty centers, home BP monitoring can be a reasonable adjunct (Flynn et al., 2022; Baker-Smith et al., 2018).
On screening, Dr Hernal is definite: “For children >3 years of age without risk factors or conditions associated with hypertension, BP measurement should be measured annually during wellness check-up beginning at age of 3 years. For children of any age with risk factors for hypertension, BP should be measured at every health visit encounter.” That routine, she maintains, is what catches hypertension before it becomes established.
Prevention first
The cornerstones of prevention and initial treatment are weight management, regular aerobic activity, adequate sleep, and higher‑quality diets. At a practical level, the DASH-style pattern (e.g. fruits, vegetables, whole grains, low-fat dairy, legumes, nuts, and fish) combined with sodium reduction (often aiming for ≤1,500–2,000 mg/day for adolescents when feasible) has been shown to lower BP and improve cardiometabolic markers (Khoury & Urbina, 2021). Emerging data associate higher dietary fiber with lower diastolic BP and healthier BMI in teens, strengthening the case for whole foods over ultra‑processed options (Carboni et al., 2023; Khoury & Urbina, 2021). Limiting sugar‑sweetened beverages, ultra‑processed foods, and energy drinks, and avoiding smoking and vaping (including e‑cigarettes) support vascular health during a critical window of arterial development (Khoury & Urbina, 2021; Carboni et al., 2023).
Dr Hernal emphasizes a family-first approach to make these changes stick. “Filipino culture tends toward collectivism, where health decisions involve parents, lola/lolo, titas, and siblings. Engaging the family, especially the cook and the decision maker, works best to most families. When everyone in the home participates, the adolescent is not singled out.” Parents, she adds, are “the primary influencers of teen behavior… [who] can reinforce lifestyle modifications by modeling healthy behaviors and building a supportive environment.”
Pharmacologic indications
Pharmacotherapy enters the picture for stage 2 hypertension, stage 1 with target‑organ damage or high‑risk conditions (e.g., chronic kidney disease, diabetes), or persistent hypertension despite 3–6 months of lifestyle therapy. Evidence supports the safety and efficacy of ACE inhibitors/ARBs, long‑acting calcium channel blockers, and thiazide diuretics in youth; medication choice is individualized to comorbidities, kidney function, and reproductive counseling considerations (Gartlehner et al., 2020). Dr Hernal aligns with this stepped approach: “A 3–6 month of lifestyle modification and weight loss is advised for asymptomatic patients with hypertension. The decision to initiate antihypertensive medication is used for children with persistently high BP, especially those with evidence of end-organ damage or other CVD risk factors and those with symptomatic hypertension.” She features the importance of regular follow‑up to track response and identify adverse effects, noting that “recommendations of the choice of agent for initial therapy are based on the underlying cause of hypertension, concurrent disorders and preference of the clinician.”
Local opportunities for action
With rapid globalization and changing food environments, adolescents in Metro Manila and other highly urbanized areas face a rising NCD burden. The ENNS platform can be leveraged alongside school‑based health programs to institutionalize BP screening, standardize measurement protocols (cuff size, positioning, rest), deliver brief lifestyle counseling, and strengthen referral pathways for elevated readings (Patalen et al., 2020). Partnerships among schools, local government units (LGUs), and primary care can scale access to validated cuffs, reinforce healthy canteen policies (less sodium, fewer sugar‑sweetened drinks), and support active transport through safer walking and cycling routes (Patalen et al., 2020).
For families, small, consistent shifts drive change: read sodium content on labels, prioritize home‑cooked meals with mindful sabaw and sawsawan moderation, keep water as the default drink, and build a nightly sleep routine that protects blood pressure and mental health (Patalen et al., 2020). Dr Hernal extends the ecosystem view beyond the household: “Most teens spend more time at school than at home. Teachers, school nurses, and administrators can reinforce health behaviors subtly but consistently by integrating health education into class activities, encouraging active lifestyles and early screening. Government has enormous power to shape health environments through policy, programs, and community resources.”
Her conclusion is a blueprint for scale, “Adolescent hypertension is not an individual issue – it is behavioral, environmental and cultural. Parents influence home habits, teachers reinforce daily routines and government shapes the environment teens grow up in. When all three work together, lifestyle changes become easy, normal, and sustainable rather than burdensome.”
Teenage dream
Adolescent hypertension demands early recognition and coordinated action from families, schools, and the health system to prevent lifelong cardiovascular harm. With better screening practices, healthier daily routines, and timely intervention, teens can be steered away from the silent risks that often go unnoticed until adulthood. The challenge now is to turn knowledge into everyday habits that shape healthier homes, classrooms, and communities. Protecting our teens today is an investment in a healthier, stronger society tomorrow.
References
Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., et al. (2017). Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics, 140(3), e20171904.
Baker-Smith, C. M., Flinn, S. K., Flynn, J. T., et al. (2018). Diagnosis, evaluation, and management of high blood pressure in children and adolescents (Technical Report). Pediatrics, 142(3), e20182096.
Khoury, M., & Urbina, E. M. (2021). Hypertension in adolescents: diagnosis, treatment, and implications. The Lancet Child & Adolescent Health, 5(5), 357–366.
Hardy, S. T., & Urbina, E. M. (2021). Blood pressure in childhood and adolescence. American Journal of Hypertension, 34(3), 242–249.
Gartlehner, G., Vander Schaaf, E. B., Orr, C., et al. (2020). Screening for hypertension in children and adolescents: Updated evidence report for the USPSTF. JAMA, 324(18), 1884–1895.
Flynn, J. T., Urbina, E. M., Brady, T. M., et al. (2022). Ambulatory blood pressure monitoring in children and adolescents: 2022 update. Hypertension, 79(8), e114–e121.
Merchant, K., Shah, P. P., Singer, P., et al. (2021). Comparison of pediatric and adult ABPM criteria for diagnosing hypertension and detecting LVH in adolescents. The Journal of Pediatrics, 230, 161–166.
Carboni, J., Basalely, A., Singer, P., et al. (2023). Dietary fiber intake and cardiometabolic risk in adolescents. The Journal of Pediatrics, 262, 113616. Patalen, C. F., Ikeda, N., Angeles-Agdeppa, I., et al. (2020). Data resource profile: The Philippine National Nutrition Survey (NNS). International Journal of Epidemiology, 49(3), 742–743f.
As pediatric experts sound the alarm, emerging body of evidence shows that high blood pressure is no longer an adults‑only condition. Filipino clinicians are being urged to screen earlier, act sooner, and mobilize families, schools, and local governments to make healthy choices the default for adolescents.
Dr Maria Theresa Hernal, a pediatrician and pharmaceutical medicine specialist, opens with a clear definition that highlights the stakes. “Pediatric hypertension is defined as having elevated systolic or diastolic blood pressure readings for the patient’s age, height and sex on three different occasions. For children 1 to <13 years of age, BP is categorized by percentiles. For children >13 years of age, elevated BP is systolic blood pressure (sBP) between 120 and 129 mmHg with a diastolic BP (dBP) <80 mmHg; stage 1 hypertension is defined as BP between 130/80 to 139/89 mmHg and Stage 2 hypertension is BP >140/90 mmHg.” She adds that for adolescents, “the definition for hypertension is aligned with the adult guidelines for the detection of elevated BP.”
Urgent relevance
Adolescent hypertension, defined in pediatric guidance as BP ≥130/80 mmHg in those aged 13–17 years, follows into adulthood and is linked with early organ changes such as left ventricular hypertrophy and increased arterial stiffness. These are not distant complications; they begin quietly in the teen years, reshaping cardiovascular outcomes (Khoury & Urbina, 2021; Hardy & Urbina, 2021). Dr Hernal’s clinical message mirrors the literature: early identification changes the curve of risk. “As a pediatrician, elevated BP should be treated proactively even though asymptomatic, focusing on lifestyle and close follow‑up. Early intervention is important as early damage occurs silently, tracks into adulthood, and prevention is easier than treatment. Pediatricians should reassure families that early intervention does not mean medication, rather it means protecting the teen’s future cardiovascular health.”
Population burden
Global estimates suggest that 4–6% of children and adolescents have hypertension, with rates rising sharply among those with obesity or chronic kidney disease (Gartlehner et al., 2020). In the Philippines, the Expanded National Nutrition Survey (ENNS) offers rolling surveillance of noncommunicable disease (NCD) risk factors, including BP, an infrastructure that positions provinces and highly urbanized cities to plan targeted interventions (Patalen et al., 2020). While consolidated national prevalence for adolescent BP from ENNS is still being synthesized across survey cycles, the system itself signals a maturing capacity to detect, track, and respond at scale (Gartlehner et al., 2020; Patalen et al., 2020). Pressure triggers
Primary (essential) hypertension has become increasingly common in adolescents, reflecting lifestyle and environmental changes: high sodium intake, low dietary fiber and potassium, insufficient sleep, sedentary behavior, psychosocial stress, and hereditary risk (Hardy & Urbina, 2021). Secondary causes, less frequent in teens than in younger children, remain clinically crucial to consider, including renal parenchymal or renovascular disease, endocrine disorders, coarctation of the aorta, and medication effects such as stimulants or steroids (Baker-Smith et al., 2018; Hardy & Urbina, 2021).
Silent but not benign
Most adolescents with hypertension have no symptoms. When present, symptoms are nonspecific (e.g. headaches, dizziness, visual disturbances, epistaxis, palpitations, or decreased exercise tolerance), making routine measurement essential (AAFP, 2018; Baker-Smith et al., 2018). Red flags for a secondary cause include severe or resistant BP elevation, onset before puberty, abnormal urinalysis or renal function, endocrine features (e.g., hyperthyroid symptoms), or diminished femoral pulses suggestive of coarctation (AAFP, 2018; Baker-Smith et al., 2018). Dr Hernal cautions that damage accumulates quietly: “Early damage occurs silently… and prevention is easier than treatment.”
Early detection
Clinic BP is the starting point, but proper technique and repeat measurements with the correct cuff size are non-negotiable. Because office readings can miss masked hypertension or overcall white‑coat hypertension, the 2017 American Academy of Pediatrics (AAP) guideline and subsequent statements recommend 24‑hour ambulatory blood pressure monitoring (ABPM) to confirm diagnosis when available. ABPM correlates better with target‑organ damage than clinic BP and helps tailor therapy; where ABPM access is limited, as in many settings outside subspecialty centers, home BP monitoring can be a reasonable adjunct (Flynn et al., 2022; Baker-Smith et al., 2018).
On screening, Dr Hernal is definite: “For children >3 years of age without risk factors or conditions associated with hypertension, BP measurement should be measured annually during wellness check-up beginning at age of 3 years. For children of any age with risk factors for hypertension, BP should be measured at every health visit encounter.” That routine, she maintains, is what catches hypertension before it becomes established.
Prevention first
The cornerstones of prevention and initial treatment are weight management, regular aerobic activity, adequate sleep, and higher‑quality diets. At a practical level, the DASH-style pattern (e.g. fruits, vegetables, whole grains, low-fat dairy, legumes, nuts, and fish) combined with sodium reduction (often aiming for ≤1,500–2,000 mg/day for adolescents when feasible) has been shown to lower BP and improve cardiometabolic markers (Khoury & Urbina, 2021). Emerging data associate higher dietary fiber with lower diastolic BP and healthier BMI in teens, strengthening the case for whole foods over ultra‑processed options (Carboni et al., 2023; Khoury & Urbina, 2021). Limiting sugar‑sweetened beverages, ultra‑processed foods, and energy drinks, and avoiding smoking and vaping (including e‑cigarettes) support vascular health during a critical window of arterial development (Khoury & Urbina, 2021; Carboni et al., 2023).
Dr Hernal emphasizes a family-first approach to make these changes stick. “Filipino culture tends toward collectivism, where health decisions involve parents, lola/lolo, titas, and siblings. Engaging the family, especially the cook and the decision maker, works best to most families. When everyone in the home participates, the adolescent is not singled out.” Parents, she adds, are “the primary influencers of teen behavior… [who] can reinforce lifestyle modifications by modeling healthy behaviors and building a supportive environment.”
Pharmacologic indications
Pharmacotherapy enters the picture for stage 2 hypertension, stage 1 with target‑organ damage or high‑risk conditions (e.g., chronic kidney disease, diabetes), or persistent hypertension despite 3–6 months of lifestyle therapy. Evidence supports the safety and efficacy of ACE inhibitors/ARBs, long‑acting calcium channel blockers, and thiazide diuretics in youth; medication choice is individualized to comorbidities, kidney function, and reproductive counseling considerations (Gartlehner et al., 2020). Dr Hernal aligns with this stepped approach: “A 3–6 month of lifestyle modification and weight loss is advised for asymptomatic patients with hypertension. The decision to initiate antihypertensive medication is used for children with persistently high BP, especially those with evidence of end-organ damage or other CVD risk factors and those with symptomatic hypertension.” She features the importance of regular follow‑up to track response and identify adverse effects, noting that “recommendations of the choice of agent for initial therapy are based on the underlying cause of hypertension, concurrent disorders and preference of the clinician.”
Local opportunities for action
With rapid globalization and changing food environments, adolescents in Metro Manila and other highly urbanized areas face a rising NCD burden. The ENNS platform can be leveraged alongside school‑based health programs to institutionalize BP screening, standardize measurement protocols (cuff size, positioning, rest), deliver brief lifestyle counseling, and strengthen referral pathways for elevated readings (Patalen et al., 2020). Partnerships among schools, local government units (LGUs), and primary care can scale access to validated cuffs, reinforce healthy canteen policies (less sodium, fewer sugar‑sweetened drinks), and support active transport through safer walking and cycling routes (Patalen et al., 2020).
For families, small, consistent shifts drive change: read sodium content on labels, prioritize home‑cooked meals with mindful sabaw and sawsawan moderation, keep water as the default drink, and build a nightly sleep routine that protects blood pressure and mental health (Patalen et al., 2020). Dr Hernal extends the ecosystem view beyond the household: “Most teens spend more time at school than at home. Teachers, school nurses, and administrators can reinforce health behaviors subtly but consistently by integrating health education into class activities, encouraging active lifestyles and early screening. Government has enormous power to shape health environments through policy, programs, and community resources.”
Her conclusion is a blueprint for scale, “Adolescent hypertension is not an individual issue – it is behavioral, environmental and cultural. Parents influence home habits, teachers reinforce daily routines and government shapes the environment teens grow up in. When all three work together, lifestyle changes become easy, normal, and sustainable rather than burdensome.”
Teenage dream
Adolescent hypertension demands early recognition and coordinated action from families, schools, and the health system to prevent lifelong cardiovascular harm. With better screening practices, healthier daily routines, and timely intervention, teens can be steered away from the silent risks that often go unnoticed until adulthood. The challenge now is to turn knowledge into everyday habits that shape healthier homes, classrooms, and communities. Protecting our teens today is an investment in a healthier, stronger society tomorrow.
References
Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., et al. (2017). Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics, 140(3), e20171904.
Baker-Smith, C. M., Flinn, S. K., Flynn, J. T., et al. (2018). Diagnosis, evaluation, and management of high blood pressure in children and adolescents (Technical Report). Pediatrics, 142(3), e20182096.
Khoury, M., & Urbina, E. M. (2021). Hypertension in adolescents: diagnosis, treatment, and implications. The Lancet Child & Adolescent Health, 5(5), 357–366.
Hardy, S. T., & Urbina, E. M. (2021). Blood pressure in childhood and adolescence. American Journal of Hypertension, 34(3), 242–249.
Gartlehner, G., Vander Schaaf, E. B., Orr, C., et al. (2020). Screening for hypertension in children and adolescents: Updated evidence report for the USPSTF. JAMA, 324(18), 1884–1895.
Flynn, J. T., Urbina, E. M., Brady, T. M., et al. (2022). Ambulatory blood pressure monitoring in children and adolescents: 2022 update. Hypertension, 79(8), e114–e121.
Merchant, K., Shah, P. P., Singer, P., et al. (2021). Comparison of pediatric and adult ABPM criteria for diagnosing hypertension and detecting LVH in adolescents. The Journal of Pediatrics, 230, 161–166.
Carboni, J., Basalely, A., Singer, P., et al. (2023). Dietary fiber intake and cardiometabolic risk in adolescents. The Journal of Pediatrics, 262, 113616. Patalen, C. F., Ikeda, N., Angeles-Agdeppa, I., et al. (2020). Data resource profile: The Philippine National Nutrition Survey (NNS). International Journal of Epidemiology, 49(3), 742–743f.